Heparin Market Players:
- Aspen Holdings
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Opocrin S.p.A.
- LEO Pharma Inc.
- Baxter
- Dr. Reddy’s Laboratories Ltd.
- Pfizer Inc.
- B. Braun Medical Inc.
- Bioiberica S.A.U.
- Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
- Fresenius Kabi Canada
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of heparin is assessed at USD 9.33 billion.
The global heparin market size was valued at around USD 8.99 billion in 2025 and is projected to grow at a CAGR of more than 4.2%, reaching USD 13.57 billion revenue by 2035.
North America’s heparin market will dominate over 39.4% share by 2035, driven by a higher number of people developing chronic kidney diseases and increasing healthcare expenditure.
Key players in the market include Aspen Holdings, Opocrin S.p.A., LEO Pharma Inc., Baxter, Dr. Reddy’s Laboratories Ltd., Pfizer Inc., B. Braun Medical Inc., Bioiberica S.A.U., Hebei Changshan Biochemical Pharmaceutical Co., Ltd., Fresenius Kabi Canada.
